Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption

被引:0
|
作者
Mdluli, Thembi [1 ,2 ]
Slike, Bonnie M. [1 ,2 ]
Curtis, Daniel J. [1 ,2 ]
Shubin, Zhanna [1 ,2 ,6 ]
Tran, Ursula [1 ,2 ]
Li, Yifan [1 ,2 ]
Dussupt, Vincent [1 ,2 ]
Mendez-Rivera, Letzibeth [1 ,2 ]
Pinyakorn, Suteeraporn [1 ,2 ]
Stieh, Daniel J. [3 ]
Tomaka, Frank L. [4 ]
Schuitemaker, Hanneke [3 ]
Pau, Maria G. [3 ]
Colby, Donn J. [1 ,2 ,5 ]
Kroon, Eugene [5 ]
Sacdalan, Carlo [5 ]
de Souza, Mark [5 ]
Phanupak, Nittaya [5 ]
Hsu, Denise C. [1 ,2 ]
Ananworanich, Jintanat [1 ,2 ]
Ake, Julie A. [1 ]
Trautmann, Lydie [1 ,2 ]
Vasan, Sandhya [1 ,2 ]
Robb, Merlin L. [1 ,2 ]
Krebs, Shelly J. [1 ]
Paquin-Proulx, Dominic [1 ,2 ]
Rolland, Morgane [1 ,2 ]
机构
[1] US Mil HIV Res Program MHRP, CIDR, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
[2] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD 20817 USA
[3] Janssen Vaccines & Prevent BV, NL-2333 CN Leiden, Netherlands
[4] Janssen R&D US, Titusville, NJ USA
[5] Inst HIV Res & Innovat, SEARCH, Bangkok 10330, Thailand
[6] US FDA, Silver Spring, MD 20903 USA
来源
CELL REPORTS | 2024年 / 43卷 / 06期
关键词
ANTIRETROVIRAL THERAPY; PROTECTIVE EFFICACY; LATENT RESERVOIR; HIGH-THROUGHPUT; CHALLENGES; STABILITY;
D O I
10.1016/j.celrep.2024.114344
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A heterologous Ad26/MVA vaccine was given prior to an analytic treatment interruption (ATI) in people living with HIV -1 (mainly CRF01_AE) who initiated antiretroviral treatment (ART) during acute HIV -1. We investigate the impact of Ad26/MVA vaccination on antibody (Ab)-mediated immune responses and their effect on time to viral rebound. The vaccine mainly triggers vaccine -matched binding Abs while, upon viral rebound post ATI, infection -specific CRF01_AE binding Abs increase in all participants. Binding Abs are not associated with time to viral rebound. The Ad26/MVA mosaic vaccine profile consists of correlated non-CRF01_AE binding Ab and Fc effector features, with strong Ab-dependent cellular phagocytosis (ADCP) responses. CRF01_AE-specific ADCP responses (measured either prior to or post ATI) are significantly higher in individuals with delayed viral rebound. Our results suggest that vaccines eliciting cross -reactive responses with circulating viruses in a target population could be beneficial and that ADCP responses may play a role in viral control post treatment interruption.
引用
收藏
页数:15
相关论文
共 18 条
  • [1] Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1
    Shangguan, Shida
    Ehrenberg, Philip K.
    Geretz, Aviva
    Yum, Lauren
    Kundu, Gautam
    May, Kelly
    Fourati, Slim
    Nganou-Makamdop, Krystelle
    Williams, LaTonya D.
    Sawant, Sheetal
    Lewitus, Eric
    Pitisuttithum, Punnee
    Nitayaphan, Sorachai
    Chariyalertsak, Suwat
    Rerks-Ngarm, Supachai
    Rolland, Morgane
    Douek, Daniel C.
    Gilbert, Peter
    Tomaras, Georgia D.
    Michael, Nelson L.
    Vasan, Sandhya
    Thomas, Rasmi
    ELIFE, 2021, 10
  • [2] HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
    Scheid, Johannes F.
    Horwitz, Joshua A.
    Bar-On, Yotam
    Kreider, Edward F.
    Lu, Ching-Lan
    Lorenzi, Julio C. C.
    Feldmann, Anna
    Braunschweig, Malte
    Nogueira, Lilian
    Oliveira, Thiago
    Shimeliovich, Irina
    Patel, Roshni
    Burke, Leah
    Cohen, Yehuda Z.
    Hadrigan, Sonya
    Settler, Allison
    Witmer-Pack, Maggi
    West, Anthony P., Jr.
    Juelg, Boris
    Keler, Tibor
    Hawthorne, Thomas
    Zingman, Barry
    Gulick, Roy M.
    Pfeifer, Nico
    Learn, Gerald H.
    Seaman, Michael S.
    Bjorkman, Pamela J.
    Klein, Florian
    Schlesinger, Sarah J.
    Walker, Bruce D.
    Hahn, Beatrice H.
    Nussenzweig, Michel C.
    Caskey, Marina
    NATURE, 2016, 535 (7613) : 556 - +
  • [3] HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
    Johannes F. Scheid
    Joshua A. Horwitz
    Yotam Bar-On
    Edward F. Kreider
    Ching-Lan Lu
    Julio C. C. Lorenzi
    Anna Feldmann
    Malte Braunschweig
    Lilian Nogueira
    Thiago Oliveira
    Irina Shimeliovich
    Roshni Patel
    Leah Burke
    Yehuda Z. Cohen
    Sonya Hadrigan
    Allison Settler
    Maggi Witmer-Pack
    Anthony P. West, Jr.
    Boris Juelg
    Tibor Keler
    Thomas Hawthorne
    Barry Zingman
    Roy M. Gulick
    Nico Pfeifer
    Gerald H. Learn
    Michael S. Seaman
    Pamela J. Bjorkman
    Florian Klein
    Sarah J. Schlesinger
    Bruce D. Walker
    Beatrice H. Hahn
    Michel C. Nussenzweig
    Marina Caskey
    Nature, 2016, 535 : 556 - 560
  • [4] Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design
    Madhavi, Vijaya
    Wren, Leia H.
    Center, Rob J.
    Gonelli, Christopher
    Winnall, Wendy R.
    Parsons, Matthew S.
    Kramski, Marit
    Kent, Stephen J.
    Stratov, Ivan
    AIDS, 2014, 28 (13) : 1859 - 1870
  • [5] Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load
    Szabó, J
    Prohászka, Z
    Tóth, FD
    Gyuris, A
    Segesdi, J
    Bánhegyi, D
    Ujhelyi, E
    Minárovits, J
    Füst, G
    AIDS, 1999, 13 (14) : 1841 - 1849
  • [6] HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV
    Madhavi, Vijaya
    Wines, Bruce D.
    Amin, Janaki
    Emery, Sean
    Lopez, Ester
    Kelleher, Anthony
    Center, Rob J.
    Hogarth, P. Mark
    Chung, Amy W.
    Kent, Stephen J.
    Stratov, Ivan
    JOURNAL OF VIROLOGY, 2017, 91 (18)
  • [7] Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
    Duchemin, Maxence
    Tudor, Daniela
    Cottignies-Calamarte, Andrea
    Bomsel, Morgane
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
    Janes, Holly
    Frahm, Nicole
    DeCamp, Allan
    Rolland, Morgane
    Gabriel, Erin
    Wolfson, Julian
    Hertz, Tomer
    Kallas, Esper
    Goepfert, Paul
    Friedrich, David P.
    Corey, Lawrence
    Mullins, James I.
    McElrath, M. Juliana
    Gilbert, Peter
    PLOS ONE, 2012, 7 (08):
  • [9] HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses
    Andres, Cristina
    Plana, Montserrat
    Guardo, Alberto C.
    Alvarez-Fernandez, Carmen
    Climent, Nuria
    Gallart, Teresa
    Leon, Agathe
    Clotet, Bonaventura
    Autran, Brigitte
    Chomont, Nicolas
    Gatell, Josep M.
    Sanchez-Palomino, Sonsoles
    Garcia, Felipe
    JOURNAL OF VIROLOGY, 2015, 89 (18) : 9189 - 9199
  • [10] Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)
    Castagna, Antonella
    Muccini, Camilla
    Galli, Laura
    Bigoloni, Alba
    Poli, Andrea
    Spagnuolo, Vincenzo
    Nozza, Silvia
    Racca, Sara
    Galli, Andrea
    Cinque, Paola
    Carini, Elisabetta
    Lazzarin, Adriano
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (07) : 2039 - 2046